Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 10;10(4):417.
doi: 10.3390/antibiotics10040417.

Essential Oils: A Natural Weapon against Antibiotic-Resistant Bacteria Responsible for Nosocomial Infections

Ramona Iseppi  1 , Martina Mariani  1 , Carla Condò  1 , Carla Sabia  1 , Patrizia Messi  1
Affiliations

Essential Oils: A Natural Weapon against Antibiotic-Resistant Bacteria Responsible for Nosocomial Infections

Ramona Iseppi et al. Antibiotics (Basel). .

Abstract

The emergence of antibiotic-resistant bacteria has become a major concern worldwide. This trend indicates the need for alternative agents to antibiotics, such as natural compounds of plant origin. Using agar disc diffusion and minimum inhibitory concentration (MIC) assays, we investigated the antimicrobial activity of Citrus aurantium (AEO), Citrus x limon (LEO), Eucalyptus globulus (EEO), Melaleuca alternifolia (TTO), and Cupressus sempervirens (CEO) essential oils (EOs) against three representatives of antibiotic-resistant pathogens and respective biofilms: vancomycin-resistant enterococci (VRE), methicillin-resistant Staphylococcus aureus (MRSA), and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Using the checkerboard method, the efficacy of the EOs alone, in an association with each other, or in combination with the reference antibiotics was quantified by calculating fractional inhibitory concentrations (FICs). All the EOs displayed antibacterial activity against all strains to different extents, and TTO was the most effective. The results of the EO-EO associations and EO-antibiotic combinations clearly showed a synergistic outcome in most tests. Lastly, the effectiveness of EOs both alone and in association or combination against biofilm formed by the antibiotic-resistant strains was comparable to, and sometimes better than, that of the reference antibiotics. In conclusion, the combination of EOs and antibiotics represents a promising therapeutic strategy against antibiotic-resistant bacteria, even protected inside biofilms, which can allow decreasing the concentrations of antibiotics used.

Keywords: ESBL; MRSA; VRE; anti-biofilm activity; antibiotic-resistant pathogens; antibiotics; essential oils; extended-spectrum β-lactamase Escherichia coli; methicillin-resistant Staphylococcus aureus; synergy association; vancomycin-resistant enterococci.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Antibacterial activity of essential oils (EOs) verified using the agar well diffusion method. Percentage of activity against tested antibiotic-resistant strains (a). Ranges of inhibitory zone diameter for VRE (b), MRSA (c), and ESBL-producing E. coli (d) strains.
Figure 2
Figure 2
Time–kill studies of EOs, antimicrobials (VAN, OXA, and CTX), and the different combinations (EO–EO, EO–antimicrobial) against VRE B5 (a), MRSA O (b), and ESBL E. coli 34 (c) strains. p-values of <0.05 (*), <0.01 (**) were considered significant by t-test and ANOVA.
Figure 2
Figure 2
Time–kill studies of EOs, antimicrobials (VAN, OXA, and CTX), and the different combinations (EO–EO, EO–antimicrobial) against VRE B5 (a), MRSA O (b), and ESBL E. coli 34 (c) strains. p-values of <0.05 (*), <0.01 (**) were considered significant by t-test and ANOVA.
Figure 3
Figure 3
Effect of selected EOs, alone and in combination with reference antibiotic, on mature biofilm formed by VRE B5 (a), MRSA O (b), and ESBL E. coli 34 (c) strains. p-values of <0.05 (*), <0.01 (**), <0.001 (***) were considered significant by t-test and ANOVA.
Figure 3
Figure 3
Effect of selected EOs, alone and in combination with reference antibiotic, on mature biofilm formed by VRE B5 (a), MRSA O (b), and ESBL E. coli 34 (c) strains. p-values of <0.05 (*), <0.01 (**), <0.001 (***) were considered significant by t-test and ANOVA.
See this image and copyright information in PMC

References

    1. Livermore D.M. Has the era of untreatable infections arrived? J. Antimicrob. Chemother. 2009;64(Suppl. 1):i29–i36. doi: 10.1093/jac/dkp255. - DOI - PubMed
    1. WHO World Antimicrobial Awareness Week-WAAW from 18 to 24 November 2020. [(accessed on 9 April 2021)]; Available online: https://www.who.int/campaigns/world-antimicrobial-awareness-week/2020.
    1. Bereket W., Hemalatha K., Getenet B., Wondwossen T., Solomon A., Zeynudin A., Kannan S. Update on bacterial nosocomial infections. Eur. Rev. Med. Pharmacol. Sci. 2012;16:1039–1044. - PubMed
    1. Cassini A., Högberg L.D., Plachoura D., Quattrocchi A., Hoxha A., Simonsen G.S., Colomb-Cotinat M., Kretzschmar M.E., Devleesschauwer B., Cecchini M., et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2019;19:56–66. doi: 10.1016/S1473-3099(18)30605-4. - DOI - PMC - PubMed
    1. Kalan L., Wright G.D. Antibiotic adjuvants: Multicomponent anti-infective strategies. Expert Rev. Mol. Med. 2011;13:e5. doi: 10.1017/S1462399410001766. - DOI - PubMed

LinkOut - more resources